DAS181 in Patients With Parainfluenza

NCT01441024 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Parainfluenza Infection

Interventions

DRUG: DAS181
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)